Pro-apoptotic and cytotoxic effects of enriched fraction of Elytranthe parasitica (L.) Danser against HepG2 Hepatocellular carcinoma

BMC Complementary and Alternative Medicine

Volumn 16, Issue 1, 2016, Pages

  Kumar, Nimmy ^a   Biswas, Subhankar ^a   Mathew, Asha Elizabeth ^a   Varghese, Subin ^a   Mathew, Jessy Elizabeth ^a   Nandakumar, K ^a   Aranjani, Jesil Mathew ^a   Lobo, Richard ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Anti proliferative; Apoptosis; Elytranthe parasitica; Gallic acid; Hepatocellular carcinoma; HepG2; Phytochemical

Indexed keywords

ACRIDINE ORANGE; ANTINEOPLASTIC AGENT; ASCORBIC ACID; CURCUMIN; DOXORUBICIN; ELYTRANTHE PARASITICA EXTRACT; ETHER; ETHIDIUM BROMIDE; FLAVONOID; GALLIC ACID; PHENOL; PLANT EXTRACT; TANNIN; UNCLASSIFIED DRUG; PHENOL DERIVATIVE; TANNIN DERIVATIVE;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BIOASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; COPPER PHENANTHROLINE ASSAY; DRUG CYTOTOXICITY; ELYTRANTHE PARASITICA; HEPG2 CELL LINE; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HUMAN; HUMAN CELL; IC50; LIVER CELL CARCINOMA; PHYTOCHEMISTRY; PLANT STEM; STAINING; SULFORHODAMINE B ASSAY; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HEP-G2 CELL LINE; LIVER TUMOR; VASCULAR PLANT;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; GALLIC ACID; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; PHENOLS; PLANT EXTRACTS; TANNINS; TRACHEOBIONTA;

EID: 84992390780     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-016-1395-3     Document Type: Article

References (52)

1. Singal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med. 2014;11(4):e1001624. doi: 10.1371/journal.pmed.1001624.
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA-Cancer J Clin. 2016;66(1):7-30.
3. EASL-EORTC Clinical Practice Guideline. Management of hepatocellular carcinoma. J Hepatol. 2012;56:908-43.
4. Acharya SK. Epidemiology of hepatocellular carcinoma in India. J Clin Exp Hepat. 2014;4 Suppl 3:S27-33. doi: 10.1016/j.jceh.2014.05.013.
5. Cabibbo G, Enea M, Attanasio M, Bruix J, Craxl A, Camm C. A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology. 2010;51(4):1274-83.
6. Pardee AD, Butterfield LH. Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities. Onco Immun. 2012;1(1):48-55. doi: 10.4161/onci.1.1.18344.
7. Keating GM, Santoro A. Sorafenib: a review of its use in advanced hepatocellular carcinoma. Drugs. 2009;69(2):223-40. doi: 10.2165/00003495-200969020-00006.
8. Hatcher H, Planalp R, Cho J, et al. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 2008;65:1631-52.
9. Liu BL, Zhang X, Zhang W, et al. New enlightenment of French Paradox: resveratrol's potential for cancer chemoprevention and anti-cancer therapy. Cancer Biol Ther. 2007;6:1833-6.
10. Ding M, Feng R, Wang SY, et al. Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity. J Biol Chem. 2006;281:17359-68.
11. Bhat GK. Flora of Udupi. Udupi, India: Indian Naturalist; 2003. p. 548-9.
12. Narasimhachar SG. Latin and Kannada names of indigenous and medicinal plants of mysore. Mysore, India: Government Press; 1969.
13. Zhengyi W, Raven P, Deyuan H. Flora of China. St Louis, USA: Missouri Botanical Garden; 2003. p. 220-39.
14. Anderson LA, Philipson JD. Mistletoe - the magic herb. The Pharm J. 1982;229:437-9.
15. Klein R. Immunology of mistletoe extracts. Phytomedicine. 2015;22:S4.
16. Kienle GS, Glockmann A, Schink M, Kiene H. Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research. J Exp Clin Can Res. 2009;28:79-112.
17. Büssing A. Immune modulation using mistletoe (Viscum album L.) extracts Iscador. Arzneimittelforschung. 2006;56(6A):508-15.
18. Melzer J, Iten F, Hostanka K, Saller R. Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. Forsch Komplementmed. 2009;16:217-26.
19. Devehat FL, Bakthiar A, Bezivin C, Amoros M, Boustie J. Antiviral and cytotoxic activities of some Indonesian plants. Fitoterapia. 2002;73:400-5.
20. Hermawan A, Murwanti R, Artanti N, Meiyanto E, et al. Effect of the water extract of Macrosolen cochinchinensis (Lour.) Tiegh. leaves on 7,12-dimethylbenz-antracene induced female mice liver carcinogensis. J Chin Pharm Sci. 2011;20(6):627-32.
21. Sodde V, Dashora N, Prabhu K, Lobo R. Evaluation of anticancer activity of Macrosolen parasiticus (L.) Danser Stem on Ehrlich's Ascites Carcinoma treated mice. Int J Can Res. 2011;7(2):135-43.
22. Sodde V, Lobo R, Kumar N, Maheshwari R, Shreedhara CS. Cytotoxic activity of macrosolen parasiticus (L.) Danser on the growth of breast cancer cell line (MCF-7). Pharmacog Mag. 2015;11 Suppl 1:S156-60. doi: 10.4103/0973-1296.157719.
23. Houghton P, Raman A. Laboratory Handbook for the fractionation of crude extracts. US: Springer; 1998. p. 54-65.
24. Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1(3):1112-6.
25. Dorman D, Hiltunen R. Antioxidant and pro-oxidant in vitro evaluation of water soluble food related botanical extracts. Food Chem. 2011;129:1612-8.
26. Aruoma OI, Murcia A, Butler J, Halliwell B. Evaluation of the anti-oxidant and pro-oxidant actions of gallic acid and its derivatives. J Agri Food Chem. 1993;141:1880-5.
27. Liu K, Liu P, Liu R, Wu X. Dual AO/EB staining to detect apoptosis in Osteosarcoma cells compared with Flow cytometry. Med Sci Monit Basis Res. 2015;21:15-20.
28. Monga J, Pandit S, Chauhan RS, Chauhan CS, Chauhan SS, Sharma M. Growth inhibition and apoptosis induction by (+)-Cyanidan-3-ol in hepatocellular carcinoma. PLoS ONE. 2013;8(7):e68710. doi: 10.1371/journal.pone.0068710.
29. Evans WC, Evans D. Trease and evans pharmacognosy. Philadelphia: Saunders Ltd; 2009.
30. Sawant L, Pandita N, Prabhakar B. Determination of gallic acid in phyllanthus emblica linn. dried powder by HPTLC. J Pharm Bioallied Sci. 2010;2(2):105-8.
31. Adesegun SA, Fajana A, Orabueze CI, Coker HAB. Evaluation of anti-oxidant properties of phaulopsis fascisepala C.B.C.I. (Acanthaceae). Evid Based Compl Alt Med. 2009;6(2):227-31.
32. Chang CC, Yang M-H, Wen H-M, Chern J-C. Estimation of total flavonoid content in propolis by two complementary colorimetric methods. J Food Drug Anal. 2002;10(3):178-82.
33. Bubba MD, Giordani E, Pippucci L, Cincinelli A, Checchini L, Galvan P. Changes in tannins, ascorbic acid and sugar content in astringent persimmons during on-tree growth and ripening and in response to different postharvest treatments. J Food Compos Anal. 2009;22:668-77.
34. Houghton P, Fang R, Techatanawat I, Steventon G, Hylands PJ, Lee CC. The sulphorhodamine (SRB) assay and other approaches to testing plant extracts and derived compounds for activities related to reputed anticancer activity. Methods. 2007;42:377-87.
35. Verma S, Mishra A. Gallic acid: molecular rival of cancer. Environ Toxicol Pharmacol. 2013;35(3):473-85. doi: 10.1016/j.etap.2013.02.011.
36. Sun G, Zhang S, Xie Y, Zhang Z, Zhao W. Gallic acid as a selective anticancer agent that induces apoptosis in SMMC-7721 human hepatocellular carcinoma cells. Oncol Lett. 2016;11:150-8.
37. Newell A, Yousef G, Lila M, Ramirez-Mares M, Mejia E. Comparative in vitro bioactivities of tea extracts from six species of Ardisia and their effect on growth inhibition of HepG2 cells. J Ethnopharmacol. 2010;130:536-44.
38. Babich H, Schuck AG, Weisburg JH, Zuckerbraun HL. Research strategies in the study of the pro-oxidant nature of polyphenol nutraceuticals. J Toxicol. 2011; doi: 10.1155/2011/467305
39. Aruoma OI, Evans PJ, Kaur H, Sutcliffe L, Halliwell B. Evaluation of the antioxidant and potential pro-oxidant properties of food additives and of Trolox C, vitamin E and probucol. Free Rad Res Commun. 1990;10:143-57.
40. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J. Vitamin C exhibits pro-oxidant properties. Nature. 1998;392-559.
41. Schumacker PT. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell. 2006;10:175-6.
42. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev. 2011;8:579-91. doi: 10.1038/nrd2803.
43. Pervaiz S, Clement MV. Tumor intracellular redox status and drug resistance - serendipity or a causal relationship? Curr Pharm Des. 2004;10:1969-77.
44. Magda D, Miller RA. Motexafin gadolinium: a novel redox active drug for cancer therapy. Semin Cancer Biol. 2006;16:466-76.
45. Maeda H, et al. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine. Cell Death Differ. 2004;11:737-46.
46. Hannun Y. Apoptosis and the dilemma of cancer chemotherapy. J Am Soc Hematol. 1997;89(6):1845-53.
47. Xiao J, Huang G, Zhu C, Ren D, Zhang S. Morphological study on apoptosis HeLa cell induced by soyasaponins. Toxicol In Vitro. 2007;21:820-6.
48. Frankfurt OS, Krishnan A. Apoptosis based drug screening and detection of selective toxicity to cancer cells. Anticancer Drugs. 2003;14:555-61.
49. Liu HR. Potential synergy of phytochemicals in cancer prevention. J Nutr. 2004;135(12):3479S-84S.
50. Li T, Zhang X, Zhao X. Powerful protective effects of gallic acid and tea polyphenols on human hepatocytes injury induced by hydrogen peroxide or carbon tetrachloride in vitro. J Med Plant Res. 2010;4(3):247-54.
51. Inoue M, Suzuki R, Sakaguchi N, Li Z, Takeda T, Ogihara Y, Jiang BY, Chen Y. Selective induction of cell death in cancer cells by gallic acid. Biol Pharm Bull. 1995;18(11):1526-30.
52. Apak R, et al. Novel pro-oxidant activity assay for polyphenols, vitamins C and E using a modified CUPRAC method. Talanta. 2013;115:583-9.